NRx Pharmaceuticals, Inc. (NRXP) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

NRx Pharmaceuticals, Inc. (NRXP) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

NRXP Cash Flow Statement

NRx Pharmaceuticals, Inc. (NRXP) cash flow statement — 9-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-8.88M	-4.29M	-3.71M	-2.89M	-4.03M	-3.48M	-1.46M	-2.31M	-3.5M	-3.67M	-3.19M	-4.56M	-7.81M	-6.09M	-8.32M	-6.27M	-14.79M	-10.38M	-11.28M	-12.01M
Operating CF Margin %	-806.09%	-402.15%	-377.72%	-1194.63%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-120.33%	-23.42%	-153.62%	-25.37%	-14.92%	5.2%	54.14%	49.47%	55.13%	39.71%	61.63%	27.16%	47.18%	41.34%	26.26%	47.85%	-3.95%	-244.28%	-2673.48%	-963.25%
Net Income	-16.52M	-1.43M	360K	-5.89M	-17.58M	-5.51M	-9.08M	-1.62M	-7.9M	-6.53M	-4.33M	-6.06M	-8.72M	-11.04M	-10.24M	-9.08M	-6.98M	-13.45M	-30.79M	-20.77M
Depreciation & Amortization	173K	165K	100K	41K	-1K	1K	1K	2K	1K	1K	1K	2K	1K	1K	1K	1K	1K	1K	395	638
Stock-Based Compensation	139K	151K	81K	68K	67K	12K	43K	104K	97K	242K	-1.2M	351K	544K	695K	766K	541K	987K	1.33M	1.57M	1.56M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	-26K	0	0	0	0	0	0	0	260.24K
Other Non-Cash Items	10.78M	-3.51M	-5.61M	2.39M	14M	2.02M	7.02M	-1.14M	2.19M	327K	-80K	359K	924K	1.76M	486K	37K	-2.6M	-2.26M	18.88M	8.34M
Working Capital Changes	-3.44M	331K	1.36M	567K	-516K	0	548K	352K	2.1M	2.29M	2.42M	812K	-564K	2.49M	670K	2.24M	-6.2M	3.99M	-937.76K	-1.4M
Change in Receivables	-50K	-48K	36K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-390	831.39K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-10.48M
Change in Payables	-1.25M	129K	13K	601K	-679K	178K	-10.17M	740K	2.12M	2.09M	1M	1.52M	-1.57M	1.7M	-92K	-910K	-1.23M	624K	-1.87M	-708.91K
Cash from Investing	-684K	-213K	-249K	-2.56M	0	0	0	0	0	0	1K	-2K	2K	-4K	1K	-5K	-3K	-3K	-388	-3.83K
Capital Expenditures	-897K	0	0	0	0	0	0	0	0	0	1K	-2K	2K	-4K	1K	-5K	-3K	-3K	-388	-3.83K
CapEx % of Revenue	81.47%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	183K	-2.56M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-432K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	29.53M	3.42M	4.58M	9.73M	1.39M	7.58M	1.26M	2.05M	4.08M	395K	-1.12M	-1.5M	6.27M	2.54M	10.12M	-28K	-860K	22.98M	1.24K	37.52M
Debt Issued (Net)	412K	0	196K	-225K	378K	4.68M	3.32M	-533K	942K	-2.15M	-1.12M	-2.67M	696K	0	10.02M	0	0	0	474	-176.47K
Equity Issued (Net)	29.12M	3.42M	1.64M	9.95M	1.01M	3.25M	-2.06M	219K	3.14M	2.55M	0	1.17M	5.58M	2.54M	92K	-28K	-342K	22.98M	878	37.69M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	2.74M	-1K	0	-350K	0	2.37M	0	0	0	0	0	0	10K	0	-518K	0	-117	0
Net Change in Cash	19.97M	-1.08M	613K	4.27M	-2.64M	4.11M	-203K	-252K	579K	-3.28M	-4.31M	-6.07M	-1.54M	-3.55M	1.8M	-6.3M	-15.65M	12.6M	-11.28M	25.5M
Free Cash Flow	-9.77M	-4.29M	-3.71M	-2.89M	-4.03M	-3.48M	-1.46M	-2.31M	-3.5M	-3.67M	-3.19M	-4.57M	-7.81M	-6.09M	-8.32M	-6.27M	-14.79M	-10.38M	-11.28M	-12.02M
FCF Margin %	-887.56%	-402.15%	-377.72%	-1194.63%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-142.6%	-23.42%	-153.62%	-25.37%	-14.92%	5.2%	54.12%	49.5%	55.12%	39.75%	61.63%	27.19%	47.21%	41.32%	26.27%	47.82%	-3.95%	-244.38%	-2660%	-963.59%
FCF per Share	-0.26	-0.13	-0.12	-0.13	-0.22	-0.21	-0.14	-0.21	-0.33	-0.41	-0.04	-0.56	-0.11	-0.09	-0.13	-0.09	-0.23	-0.16	-0.22	-0.22
FCF Conversion (FCF/Net Income)	0.54x	3.00x	-10.31x	0.49x	0.23x	0.63x	0.16x	1.42x	0.44x	0.56x	0.74x	0.75x	0.90x	0.55x	0.81x	0.69x	2.12x	0.77x	0.37x	0.32x
Interest Paid	0	0	0	0	0	0	0	0	0	374K	239K	0	205K	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0